What is Currently the Best for Adenocarcinoma without Driver Mutation?

by Cheol-Kyu Park, M.D., Ph.D., In-Jae Oh, M.D., Ph.D., Young-Chul Kim, M.D., Ph.D.
Published 2018-07-01

Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression

by Ha-Young Park, M.D., In-Jae Oh, M.D., Ph.D., Bo Gun Kho, M.D., Tae-Ok Kim, M.D., Hong-Joon Shin, M.D., Cheol Kyu Park, M.D., Ph.D., Yong-Soo Kwon, M.D., Ph.D., Yu-Il Kim, M.D., Ph.D., Sung-Chul Lim, M.D., Ph.D., Young-Chul Kim, M.D., Ph.D., Yoo-Duk Choi, M.D., Ph.D.
Published 2019-07-01